OTC Watch

All stocks / BIOE

Bio Essence Corp BIOE

Bio Essence (BIOE): shares outstanding up 42% in a year, 1 insider sale or sale notice in 90 days and the latest annual figures in plain language. Each fact links to its SEC filing.

DilutionEstimated floatInsider selling OTCQBCalifornia, USA
Live quote on OTC Markets

Market listing

Full name
BIO ESSENCE CORP
Market tier
OTCQB
Trading status
Active
Last trade
Nov 13
Website
www.bioessencecorp.com
Source: Stockwatch, 2026-11-17

News headlines

Bio Essence Unveils Practitioner-Controlled Knowledge Vault, Tackling AI's Trust Barrier in Healthcare
2026-10-29 08:00 · News Release
Bio Essence Corp Appoints Xiying (Thea) Zhang and Geoff Fellows as Independent Directors to Its Board
2026-10-26 08:00 · News Release
Bio Essence Corporation Expands MediFlow Platform with Development of Practitioner-Specific AI and RAG Technology
2026-10-15 08:00 · News Release
Bio Essence Corporation (OTCQB: BIOE) to Acquire MediFlow AI Platform, Strengthening Its Human Health and Wellness Portfolio
2026-04-27 08:00 · News Release
BIO ESSENCE CORP (OTCQB:BIOE) Announces Approval for Upgrade to the OTCQB Market, Effective February 26, 2026
2026-03-03 08:00 · News Release
BIO ESSENCE CORP (OTC Pink: BIOE) Announces Commencement of Regulation A Tier 2 Offering for up to $5.0 Million
2026-02-03 09:00 · News Release
Headlines only, with links to the full item. Company press releases are written by the company.

The financial report, and what it means

Annual figures to 2025-12-31
The report says
Revenue
$1,897,566
Net income
$896,197
What it means

It earned more than it spent

Steady

After all costs, the company kept $896,197 as profit in the year.

The report says
Total assets
$422,474
Total liabilities
$2,495,367
What it means

It owes more than it owns

Under strain

Everything the company owns adds up to $422,474. Its debts and unpaid bills add up to $2.5 million. That is about $5.91 owed for every $1 owned.

What this adds up to

1 of 2 checks show strain. It owes more than it owns. These are facts from the company's own reports, not a recommendation.

Signals

Dilution2026-11-12

Shares outstanding rose from 38,009,000 (2025-11-15) to 53,809,000 (2026-11-12), up 42%.

Rule: Shares outstanding up 20% or more in 12 months. Source record

Estimated float2026-11-12

Estimated float about 40,413,000 shares as of 2026-11-12: 53,809,000 outstanding minus 13,396,000 held by 1 reporting insider(s).

Rule: Estimated: shares outstanding minus the latest holdings insiders reported on Forms 3/4/5. Holders of 5% or more (13D/13G) are not yet subtracted. Source record

Insider selling2026-10-13

YIN YAN filed notice of a proposed sale of 550,000 shares (Form 144, 2026-10-13).

Rule: Form 4 or Form 144 sale in the last 90 days. Source record

Shares outstanding

Source: SEC filings
2025-12-31
38.0M
2026-03-27
38.0M
2026-03-31
46.8M
2026-05-15
46.8M
2026-06-30
53.8M
2026-08-14
53.8M
2026-09-30
55.8M
2026-11-12
53.8M

Price chart

Chart by TradingView. We do not store or publish prices. Live quote on OTC Markets

Recent filings

2026-11-13 10-QQUARTERLY REPORT
2026-10-23 8-KCURRENT REPORT
2026-10-21 PRE 14CPRELIMINARY INFORMATION STATEMENT
2026-10-14 4/A
2026-10-13 144
2026-08-14 10-QQUARTERLY REPORT
2026-05-19 8-K/AAMENDMENT NO. 1 TO FORM 8-K
2026-05-15 10-QQUARTERLY REPORT
2026-04-24 8-KCURRENT REPORT
2026-03-27 10-KANNUAL REPORT
2026-01-05 QUALIF

Common questions about BIOE

Does BIOE file reports with the SEC?

Yes. Bio Essence files with the SEC under company number 0001723059. The most recent filing we hold is a 10-Q dated 2026-11-13.

Source record

How many BIOE shares are outstanding?

53,809,000 shares as of 2026-11-12, as reported to the SEC. That is up 42% from 38,009,000 on 2025-11-15.

Source record

Has BIOE filed reports late?

We found no late-filing notices (NT 10-K or NT 10-Q) in its last 12 months of SEC filings.

Have BIOE insiders sold shares recently?

1 insider sale or sale notice was filed in the last 90 days. Most recent: YIN YAN filed notice of a proposed sale of 550,000 shares (Form 144, 2026-10-13).

Source record

Who runs Bio Essence?

Officers named in its insider filings: Yin Yan (Chief Executive Officer).

Source record

Is Bio Essence making money?

After all costs, the company kept $896,197 as profit in the year. (Annual figures to 2025-12-31. Facts from the company's own report, not a recommendation.)

Source record